Stay updated on Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.

Latest updates to the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a small backend/software update rather than a substantive change to study details.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now shows a new site revision number (v3.6.4) replacing the previous v3.6.3. This reflects a deployment update rather than a change to the study details.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision: v3.6.3 replaces the previous v3.6.2 in the study materials, indicating a newer revision of the provided documents.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a newer site build. This change does not modify the study details, data, or visible content on the page.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading, while the older 'Intervention / Treatment' heading was removed. A new Revision: v3.6.0 tag is introduced.SummaryDifference0.3%

- Check74 days agoChange DetectedThe page’s revision label has been updated from v3.5.4 to v3.5.5, indicating an internal update to the page system without changing visible trial information.SummaryDifference0.0%

Stay in the know with updates to Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.